New report highlights access gap for innovative medicines

Jul 27, 2026

The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia.

The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable countries (including medicines for babies with CAH), citing funding pressures and lengthy reimbursement processes as key factors.
  Read the full report here:   https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2026/07/03826-MA-BitterPill-Report_Accessible_Final.pdf (Summary and title image generated using AI)

Recent Blog Posts

Supporting Safer Adrenal Crisis Care

Supporting Safer Adrenal Crisis Care

The Addison’s Disease Self-Help Group (ADSHG) has launched a national advocacy campaign to improve emergency treatment and patient safety for people at risk of adrenal crisis. The campaign was sparked by the discontinuation of liquid hydrocortisone in the UK, which...

The CAH Support Group is affiliated with Society for Endocrinology, an organisation that supports clinicians, scientists and nurses who work with hormones throughout their careers. They engage policy-makers, journalists, patients and the public with hormone science to encourage informed health decisions, and to demonstrate the value of endocrinology to the wider world and also maintains a public information website, You and Your Hormones.

All content on this website (livingwithcah.com) is copyright the CAH Support Group unless otherwise stated.

The CAH Support Group cannot be held responsible for the content provided by any external links unless stated.

Cookie Policy | Privacy Policy | Disclaimer | Forum & Social Media Rules | Contact Us